Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
1. The use of LMWH following open reduction and internal fixation of ankle fractures will
reduce the number of thrombi formed.
2. The rates of clinically significant DVT will be equivalent between two groups.